Acquisition by Shameze Rampertab of 81521 shares of Asensus Surgical subject to Rule 16b-3

About 67% of Asensus Surgical's investor base is looking to short. The analysis of current outlook of investing in Asensus Surgical suggests that many traders are alarmed regarding Asensus Surgical's prospects. The current market sentiment, together with Asensus Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use Asensus Surgical stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Asensus Surgical Officer Evp, Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Asensus insider trading alert for acquisition of common stock by Shameze Rampertab, Officer: Evp, Chief Financial Officer, on 23rd of April 2024. This event was filed by Asensus Surgical with SEC on 2024-04-21. Statement of changes in beneficial ownership - SEC Form 4

Asensus Surgical Fundamental Analysis

We analyze Asensus Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asensus Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asensus Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

Asensus Surgical is currently under evaluation in target price category among its peers.

Asensus Surgical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Asensus Surgical stock to make a market-neutral strategy. Peer analysis of Asensus Surgical could also be used in its relative valuation, which is a method of valuing Asensus Surgical by comparing valuation metrics with similar companies.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Asensus Stock

If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets